Lab AP Conf Minutes 2015-Sept-08: Difference between revisions

From IHE Wiki
Jump to navigation Jump to search
Skrejci (talk | contribs)
Skrejci (talk | contribs)
Line 1: Line 1:
 
 
==Attendees==
<table>
<table>
<tbody>
<tbody>
<tr>
<tr>
<td width="145">Carolyn Knapik</td>
<td width="185">Carolyn Knapik</td>
<td width="132">CAP</td>
<td width="128">CAP</td>
</tr>
</tr>
<tr>
<tr>
<td width="145">Francois Macary</td>
<td width="185">Francois Macary</td>
<td width="132">
<td width="128">
<table width="439">
<table width="439">
<tbody>
<tbody>
Line 21: Line 20:
</tr>
</tr>
<tr>
<tr>
<td width="145">Riki Merrick</td>
<td width="185">Riki Merrick</td>
<td width="132">APHL</td>
<td width="128">APHL</td>
</tr>
</tr>
<tr>
<tr>
<td width="145">John Hopson</td>
<td width="185">John Hopson</td>
<td width="132">Abbott</td>
<td width="128">Abbott</td>
</tr>
</tr>
<tr>
<tr>
<td width="145">Naomi Ishii</td>
<td width="185">Naomi Ishii</td>
<td width="132">JAHIS</td>
<td width="128">JAHIS</td>
</tr>
</tr>
<tr>
<tr>
<td width="145">Laurent Lardin</td>
<td width="185">Ed Heierman</td>
<td width="132">
<td width="128">Abbott</td>
<table width="439">
<tbody>
<tr>
<td width="169">BioMerieux</td>
<td width="162">BioMerieux</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tr>
<tr>
<tr>
<td width="145">Ed Heierman</td>
<td width="185">Dmytro Rudd</td>
<td width="132">Abbott</td>
<td width="128">Roche</td>
</tr>
</tr>
<tr>
<tr>
<td width="145">Dmytro Rudd</td>
<td width="185">Benoit Denisselle</td>
<td width="132">Roche</td>
<td width="128">&nbsp;</td>
</tr>
</tr>
<tr>
<tr>
<td width="145">Benoit Denisselle</td>
<td width="185">Christel Daniel</td>
<td width="132">&nbsp;</td>
<td width="128">AP-HP</td>
</tr>
</tr>
<tr>
<tr>
<td width="145">Christel Daniel</td>
<td width="185">Joanna Selinsky</td>
<td width="132">AP-HP</td>
<td width="128">Beckman Coulter</td>
</tr>
</tr>
<tr>
<tr>
<td width="145">Joanna Selinsky</td>
<td width="185">James Harrison</td>
<td width="132">Beckman Coulter</td>
<td width="128">CAP</td>
</tr>
</tr>
<tr>
<tr>
<td width="145">James Harrison</td>
<td width="185">Raj Dash, MD, FCAP</td>
<td width="132">CAP</td>
<td width="128">CAP</td>
</tr>
</tr>
<tr>
<tr>
<td width="145">Raj Dash, MD, FCAP</td>
<td width="185">Alessandro Sulis</td>
<td width="132">CAP</td>
<td width="128">CRS4</td>
</tr>
</tr>
<tr>
<tr>
<td width="145">Alessandro Sulis</td>
<td width="185">Charles Parisot</td>
<td width="132">CRS4</td>
<td width="128">&nbsp;</td>
</tr>
</tr>
<tr>
<tr>
<td width="145">Charles Parisot</td>
<td width="185">Laurent Lardin</td>
<td width="132">&nbsp;</td>
<td width="128">BioMerieux</td>
</tr>
</tr>
</tbody>
</tbody>

Revision as of 10:08, 9 September 2015

 

<tbody> </tbody>
Carolyn Knapik CAP
Francois Macary <tbody> </tbody>
ASIP Sante
Riki Merrick APHL
John Hopson Abbott
Naomi Ishii JAHIS
Ed Heierman Abbott
Dmytro Rudd Roche
Benoit Denisselle  
Christel Daniel AP-HP
Joanna Selinsky Beckman Coulter
James Harrison CAP
Raj Dash, MD, FCAP CAP
Alessandro Sulis CRS4
Charles Parisot  
Laurent Lardin BioMerieux

Minutes

Joint activities

  • Agenda Review:
  • Timeslot for AP report progression:
      • Still organizing getting together with the German colleagues – will aim for second hour of next month’s call or will send doodle– Note: October is the F2F visit in Tokyo
      • German team has started to migrate the current revisions of APSR into Art Décor using a single AP observation template
      • Ongoing effort to define top list of codes (for now PathLex codes to be migrated into LOINC) that can be used in CDA document – organ specific and general
      • Next steps:
        • Working on PSR document – have not managed to meet with the art décor team to create the new = this is a little ahead of current
        • Take last release of APSR and migrate is as into Art Décor
        • Update the next update of APSR based on the agreed CP for now
      • The choice of the committee is to first migrate the current APSR specification into Art Décor, and then evaluate the output. Second, a distinct project (introduced through the regular “supplement proposal” process of IHE) will be to reuse this base material to build the “PSR” project, in the scope of the merged domain.
  • Update on Merger Voting (Carolyn Knapik)
      • Tally from last Thursday: 8 yes, 1 no – voting ends 9/16, so please vote, if you haven’t done so already
      • Quorum for just IHE Lab was 4 – Carolyn will get quorum requirements from Chris Carr, might be hard to figure out which domain some folks belong to, as they belong to both, but get only 1 vote
  • Update on LCC (James Harrison)
      • Nothing new to report
  • Managing distributed review and editing within Art Décor
      • Easy to represent the entry templates, but unsure about how to build  the larger value sets from SNOMED CT or LOINC – not specifically an issue for APSR, as the template has simple structure, but how to better represent the LOINC observation codes
      • How far can we include SCT for value set generation – technical question:
  • Building valuesets is possible in Art Décor – can be used to build from any reference terminology already loaded into the tool = ICD-10, LOINC, SCT (latest version of international)
        • Would have to load PathLex into the tool, before we could use it to build out value sets based on PathLex
        • Verify with German team
        • Validate platform on clear scope of APSR first, then expand to PSR
  • Prepare question(s) for Mary and Riki to present to board (Riki Merrick)
      • Using Art décor as a publishing tool – what are the rules for changes and publication etc.
      • How will Art Décor be connected to Gazelle tool for schematron – Eric has been working on a procedure to take the output of Art Décor and translate/ import into Gazelle tool (object checker – there is MOU between IHE Europe and Art Décor team)
      • Where is the official instance of Art Décor for IHE?
        • US is using an instance of Art Décor for a profile and Gazelle team is using that same instance
        • Invite Eric to a next call to present the status of migration, possibly during the next face to face.
      • Governance of Art Décor content?
    • Feedback from DICOM Pathology meeting (Charles Parisot):
      • Reviewed the proposed merger between AP and Lab – interested in tracking that – DICOM AP is supportive of this process and will monitor
      • Plan for interoperability showcase(DICOM/IHE sponsored – working through the admin side of that) at May meeting of European College of Pathology in Berlin – workflow / including use of IHE profile – with possible repeat at CAP ‘16 in October – need more coordination
      • Review of scenarios for the interoperability showcase – will have to create multiple, more complex scenarios that will use more IHE content in the long run
  • F2F meeting logistics (Naomi Ishii)
      • 9/19 – 21 – 3 full days – 9 AM– 5 PM local time
      • Recommended hotels – Naomi to send on September 9
      • Have meeting venue at JAHIS at Shinbashi station
  • LAW (Ed Heierman)
    • Status update:
      • In progress on working with CLSI on creating the standard based on LAW – first draft due this month
      • In process of collecting and creating final CPs prior to NA so that it can then be in TF (straightforward so far):
        • Handling of profile option identifier
        • Profile that should be optional on analyzer
        • LAB-28 message structure choices
        • OBX-4 usage
        • Pooling of specimen
        • Updatable / truncatable length
        • Tracing inventory segments to one or more OBXs
        • Minor edits to document
      • LAW will be spotlighted for NA, also IICC will help with publicizing the NA connectathon t make this major testing event for LAW
      • Gathering vendors for NA connectathon end of January 2016 in Cleveland
      • For F2F hope to have all CPs reviewed and approved at end of the F2F in preparation for NA. We’ll allocate two time slots for this CP review during F2F.
  • Technical Discussions
    • LSH (John Hopson)
      • Status
    • Should have supplement for first use case by F2F
    • 2 time slots reserved for LSH at F2F, on two separate days.
      • So just 1 use case per Trial Implementation release - we have 1 year for testing and use case 1 MUST have enough interest of vendors to get proper testing – at least at NA, Europe and Japan connectathons
  • Transactions
    • Discuss HL7 Carrier/Tray Status Messages
    • Message Structure
      • Have 3 specific transactions
      • Reviewing command and response:
            • SAC segment where device identifies the specimen can be omitted – so changed usage in LSH.3 to RE
      • Reviewing Chapter 13 – how do you communicate carrier and tray status to the automation manager – have specimen status and container status SAC-8 - can identify the tray / container, but nothing specifically to the status of the carrier / tray – ask Andrzej Knafel, main author of Chapter 13
      • Type of statuses: complete processing, etc – Dmytro will draft suggestion for these new fields – John will provide the detail Dmytro would need to write up a CR for OO
      • OO usually meets on Thursday 1 PM ET – Riki will let him know when it is on the agenda
    • F2F meeting needs: 3-4 hours – may a 3 hour block plus 1 hour next day for follow up work?
    • Who will attend October F2F in person?
    • Dmytro via webex
    • Alessandro in person
    • Riki via webex only most likely
    • Will send out draft agenda and an RSVP request to the list

    Call adjourned  10:50 AM EDT